Physician profile
Mark A Bird
NPI 1710940325
$5,619.50
in general payments reported to CMS, 2019-2025
10 companies · $1,844 in 2025
The $1,844 reported for 2025 was more than what 81% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.62 · 2020: $36.44 · 2021: $39.27 · 2022: $55.10 · 2023: $99.20 · 2024: $3,498 · 2025: $1,844.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,236 · Food and Beverage: $1,030 · Education: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,236.38 |
| Food and Beverage | $1,030.32 |
| Education | $174.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,323.40 | 2024-2025 | |
| Inspire Medical Systems, INC. | $89.04 | 2023 | Inspire |
| Smith+Nephew, INC. | $46.21 | 2019-2025 | Stravix Pl |
| Masimo Corporation | $42.76 | 2022 | |
| Medtronic, INC. | $26.04 | 2021-2022 | |
| Trevena, INC. | $25.57 | 2021 | |
| Biom'Up France Sas | $22.94 | 2020 | |
| Avanos Medical | $19.88 | 2019 | |
| Bard Peripheral Vascular, INC. | $13.50 | 2020 | |
| Lifenet Health | $10.16 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Bird listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.